Godrej Agrovet
Q2 revenue rose 17% to ₹2,995 Cr, but EBITDA was flat at ₹222 Cr and PBT rose only 5%. Management concedes a tougher FY27 but is still chasing double-digit PBT growth.
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every Godrej Agrovet earnings call we streamed: the live audio and our summary of what management said.
Q2 revenue rose 17% to ₹2,995 Cr, but EBITDA was flat at ₹222 Cr and PBT rose only 5%. Management concedes a tougher FY27 but is still chasing double-digit PBT growth.
Q2 revenue rose 17% to ₹2,995 Cr, but EBITDA was flat at ₹222 Cr and PBT rose only 5%. Management concedes a tougher FY27 but is still chasing double-digit PBT growth.
Oil palm margin +~2pp in midterm (2-3 years); CDMO share 50-55% midterm; FY27 double-digit PBT growth now uncertain.
Godrej Agrovet delivered 10% revenue growth in Q1 FY27, driven by strong animal nutrition and oil palm segments. However, a dry June delayed Kharif sowing, hurting domestic crop protection volumes and profitability.
Godrej Agrovet delivered a strong Q4 FY26 with 9% revenue growth and 16.8% PBT growth. The company surpassed the ₹10,000 crore annual revenue milestone with improved margins.
Godrej Agrovet surpassed ₹10,000 Cr revenue in FY26, achieving record profitability driven by 68% EBIT growth in Oil Palm and sustained Animal Nutrition volumes, despite challenges in Dairy and Crop Care.
Godrej Agrovet surpassed ₹10,000 Cr revenue in FY26 with all-time high profitability. Strong performance in Oil Palm and Animal Nutrition offset headwinds in Dairy and Crop Care.
Godrej Agrovet surpassed ₹10,000 Cr revenue in FY26 with record profitability. Growth driven by Oil Palm and Animal Nutrition segments, offsetting challenges in Dairy and Crop Care.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.